Skip to main content
Signal8

ZYXI (ZYXI)

Zynex, Inc. logo

Zynex, Inc.

NASDAQ:ZYXIHealthcare
Mkt Cap-
Float15.79M
O/S-
Inst Own-
Dilution
Historical Data
DateOpenHighLowCloseVolume
Key Metrics
Market Cap--
Enterprise Value--
P/E Ratio--
Est. Net Cash/Share--
Institutional Ownership--
SectorHealthcare
IndustryMedical - Distribution
ExchangeNASDAQ
CountryUSUS
IPO DateFeb 25, 2004
Shares Outstanding-
Float15.79M
Company Overview

Zynex, Inc., operating through its subsidiaries, specializes in the development, production, and sale of medical devices. These devices primarily utilize electrical stimulation to alleviate both chronic and acute pain, and to stimulate and exercise muscles for rehabilitation.

The company's core product offerings include NexWave, a versatile, dual-channel device combining interferential current, transcutaneous electrical nerve stimulation (TENS), and neuromuscular electrical stimulation (NMES), which is actively marketed to physicians and therapists by its field sales force. Other significant products are NeuroMove, an electrical stimulator activated by electromyography; InWave, specifically designed for treating female urinary incontinence; and E-Wave, another type of NMES device. Zynex also provides private-label accessories, such as electrodes for conducting electrical currents to the body and batteries for powering electrotherapy products. Beyond its own manufactured goods, the company acts as a distributor for several third-party medical items. These include Comfortrac/Saunders for cervical traction, JetStream for therapeutic hot/cold applications, LSO Back Braces for lumbar support, and various knee braces. Expanding its technological portfolio, Zynex offers advanced monitoring solutions. This includes the Zynex Fluid Monitoring System (CM-1500), a non-invasive device that tracks relative fluid volume changes in surgical and recovery settings to identify fluid loss during operations or internal bleeding afterward. A wireless version, the CM-1600, provides similar non-invasive fluid volume monitoring for adult patients.

Additionally, the company supplies the NiCO CO-Oximeter and the HemeOx tHb Oximeter, both non-invasive, laser-based devices for co-oximetry and total hemoglobin pulse oximetry, respectively. Zynex's diverse product range is utilized across various medical applications, including pain management, rehabilitation for stroke and spinal cord injuries, hemodynamic monitoring, and pulse oximetry.

The company distributes its products primarily through its direct sales force, mainly within the United States. Established in 1996, Zynex, Inc. is based in Englewood, Colorado.

Leadership

Thomas Sandgaard

Founder, President & Chairman

Vikram Bajaj

Chief Financial Officer

Ajay Gopal

Executive Vice President of Sales

Donald Gregg

President of Zynex Monitoring Solutions

Employees

1K+

Country

US

Sector

Healthcare

Website

zynex.com

Analyst Coverage
Analyst Coverage
ConsensusBuy
Price Target
No price targets available
Ratings Distribution
BUY
6
HOLD
3
SELL
0
TOTAL9
Insider Trades
InsiderTypeShares
Cress Michael D profile photoCress Michael DWithholding/Transfer12.5K
Cress Michael D profile photoCress Michael DWithholding/Transfer82.5K
MICHAELS BARRY D profile photoMICHAELS BARRY DWithholding/Transfer80.0K
Disbrow Joshua R. profile photoDisbrow Joshua R.Withholding/Transfer12.5K
Disbrow Joshua R. profile photoDisbrow Joshua R.Withholding/Transfer89.5K
Lucsok Anna profile photoLucsok AnnaAutomatic Sell3.8K
Shareholders
--
Institutional
(1)
--
Insiderⓘ
(3)
--
5%+ Owners
(0)
--
Unattributed (incl. retail)ⓘ
Sources: 13F, Form 4
Insiders & Institutional Holders

Insiders

Top institutional holders

52-Week Range
Volume
Average Daily Volume--

30d Avg

--

60d Avg

--

90d Avg

--

Earnings
Dividend History
TTM Yield
--
Annual (LTM)
--
Latest
$0.1000
Jan 5, 22
5Y Growth
--
Compliance Status
Loading compliance data...